Arena Pharmaceuticals Inc (ARNA)
PHARMACEUTICAL PREPARATIONS
Arena Pharmaceuticals Inc (ARNA) was listed on Nasdaq from July 28, 2000 and stopped trading under the symbol ARNA on March 14, 2022.
- Listed On
- Nasdaq
- Listed Since
- July 28, 2000
- Stopped Trading
- March 14, 2022
- Employees
- 448
About Arena Pharmaceuticals Inc
Arena Pharmaceuticals is a biotechnology company targeting G-protein-coupled receptors. The company has one internally discovered drug, lorcaserin, which has been approved and is marketed in the U.S. and South Korea to target weight management. It is commercialized under the brand name Belviq. The company is collaborating with Eisai to market Belviq in other countries. It has a presence in Europe through its Swiss subsidiary, Arena GmbH. The company's pipeline contains drugs targeting autoimmune diseases, vascular diseases, thrombotic diseases, dementia-associated psychosis, nervous system issues, and pain.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 1 institution reported holding ARNA, with 2 shares worth $101 in aggregate. The largest reported holder was Huntington National Bank, with 2 shares worth $101. Of the 1 largest holders listed below, 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Huntington National Bank | 2 | $101 | Unchanged |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is ARNA?
Arena Pharmaceuticals Inc (ARNA) was listed on Nasdaq from July 28, 2000 and stopped trading under the symbol ARNA on March 14, 2022.
Who are the largest institutional holders of ARNA?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of ARNA were Huntington National Bank.
How many institutions own ARNA?
1 institution reported a position in ARNA for the quarter ended June 30, 2026, worth $101 in total.
Did institutions buy or sell ARNA last quarter?
Of the 1 largest reported holders, 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for ARNA.
Every reported institutional holder, plus insider and congressional trades in ARNA, on SentiSense.